Patient and Healthcare Professional Preferences for Characteristics of Long-Acting Injectable Antipsychotic Agents for the Treatment of Schizophrenia.

Delbert G RobinsonMark SuettAmanda WilhelmNayla ChaijaleKelli R FranzenburgSanjay GandhiBlaine CloudMarko Mychaskiw

Published in: Advances in therapy (2023)

Patients had a range of responses, and on some issues patient and HCP preferences differed. Altogether, this suggests the importance of providing patients with a range of options and the importance of patient-HCP discussions on treatment preference for LAIs.

Keyphrases

healthcare
case report
end stage renal disease
newly diagnosed
bipolar disorder
peritoneal dialysis
combination therapy
smoking cessation